PAVmed Inc. (PAVM) Tops Q3 EPS by 12c

PAVmed Inc. (NASDAQ: PAVM) reported Q3 EPS of ($0.15), $0.12 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $76 thousand versus the consensus estimate of $233.33 thousand.

For earnings history and earnings-related data on PAVmed Inc. (PAVM) click here.

You May Also Be Interested In

• AngioDynamics (ANGO) Tops Q4 EPS by 2c ; Offers Guidance
• First Solar (FSLR) PT Raised to $279 at Barclays
• BofA Securities Upgrades AptarGroup (ATR) to Buy